
Fate Therapeutics Inc
FATENasdaqCIK 1434316HealthcareFiscal year ends Dec 31
Reports and events: 227 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0817:10 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-273633 |
| 2023-11-0816:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061080 |
| 2023-11-0816:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-061077 |
| 2023-09-0117:29 ET | 8-K | 8.01 Other events | 0001193125-23-227749 |
| 2023-08-0816:09 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039803 |
| 2023-08-0816:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039783 |
| 2023-06-0916:08 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-027262 |
| 2023-06-0816:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-027007 |
| 2023-06-0708:52 ET | 8-K | 8.01 Other events | 0000950170-23-026747 |
| 2023-05-0316:10 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-017175 |
| 2023-05-0316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-017157 |
| 2023-04-2116:04 ET | DEF 14A | Proxy statement | 0001193125-23-110475 |
| 2023-04-1917:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-047252 |
| 2023-04-1916:06 ET | 8-K | 3.01 Delisting notice; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-23-013471 |
| 2023-02-2816:06 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-005067 |
| 2023-02-2816:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-005063 |
| 2023-01-0517:04 ET | 8-K | 1.02 Termination of a material agreement; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-002504 |
| 2022-11-0713:21 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-022488 |
| 2022-11-0316:05 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-021840 |
| 2022-11-0316:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-021834 |
| 2022-08-0316:08 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-014236 |
| 2022-08-0316:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-014223 |
| 2022-06-3016:06 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-012381 |
| 2022-06-1316:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-22-011554 |
| 2022-05-0416:16 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-007389 |
| 2022-05-0416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-007377 |
| 2022-04-2516:03 ET | DEF 14A | Proxy statementPeriod 2022-06-09 | 0001193125-22-117516 |
| 2022-02-2816:13 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-002293 |
| 2022-02-2816:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-002285 |
| 2021-12-1417:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-356947 |
| 2021-11-0416:59 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-21-320325 |
| 2021-11-0416:13 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-003066 |
| 2021-11-0416:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-21-003055 |
| 2021-08-0416:13 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-040821 |
| 2021-08-0416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-040793 |
| 2021-08-0409:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-235830 |
| 2021-06-0716:50 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-21-184402 |
| 2021-05-0516:07 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-024037 |
| 2021-05-0516:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-024017 |
| 2021-04-2116:11 ET | DEF 14A | Proxy statementPeriod 2021-06-02 | 0001193125-21-124699 |
| 2021-03-2516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001564590-21-015473 |
| 2021-02-2416:09 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-008086 |
| 2021-02-2416:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-008069 |
| 2021-01-1216:18 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-21-003451 |
| 2021-01-0816:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-005180 |
| 2020-12-2216:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001564590-20-058034 |
| 2020-12-0709:00 ET | 8-K | 8.01 Other events | 0001564590-20-056247 |
| 2020-11-0516:07 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-051301 |
| 2020-11-0516:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-20-051284 |
| 2020-08-1916:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-20-040672 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 10:50 ET. Listed shows no prices and gives no investment advice.